glp 1 vs weight loss surgery GLP-1 vs. Bariatric Surgery: 1- Surgery: 25-30% + TBWL for 10+ years GLP-1: 15-21% in trials, less in real-world 2- Metabolic Benefits: > GLP-1 3- Comorbidities: Greater resolution with glp-1 agonists vs bariatric surgery

However, it did not effectively reduce disease activity or proteinuria in LN patients (77)

We recently reported studies examining a novel glycolipid surfactant-peptide conjugation technology designed to prolong in vivo terminal elimination half-life (T 1/2 ) and demonstrated its tunable impact on pharmacokinetic (PK) parameters for analogs of both parathyroid hormone 19 and GLP-1R/GCGR dual agonists 20

(PubMed) Padayatty SJ, Sun H, Wang Y, et al

All use of sermorelin should be under medical supervision with appropriate monitoring of efficacy and safety parameters

Microbial metabolites and intestinal stem cells tune intestinal homeostasis

See the complete Peptides & GLP-1 collection